blank_image_placeholder

BSL-3 Preclinical Services

by CCP

Service Description:

The animal BSL-3 laboratory at the Czech Centre for Phenogenomics (CCP) specialises in infectious disease research using animal models. CCP conducts studies on viral, bacterial, protozoal, and other diseases in both generic and transgenic rodents, ensuring strict safety and quality control. Supported by various modules and experts, they design, perform, and evaluate disease severity and progression, therapeutic efficacy, and vaccination studies. Additionally, CCP conducts common follow-up in vitro evaluations. Their services include both short and long-term experiments, focusing on coherent and reproducible results. Their expertise extends to various areas related to animal biochemistry, pathology, immunology, and other fields, allowing for comprehensive collaboration at the centre.

Included in the Service:

CCP provides robust and comprehensive solutions for testing and experimentation. Their services include complete administrative support, such as obtaining licenses for animal testing, GMO compliance, and working with infectious biological substances. They handle the acquisition, husbandry, and breeding of animals, including the design and husbandry of tailored transgenic animals. CCP offers testing of various in vitro and in vivo modalities, including lung function, cardiography, hematoanalysis, and can implement new services based on the requestor’s needs. In collaboration with other units, CCP provides follow-up tests, such as immunology panels for infected animals, metabolic and biochemical markers, and subsequent histopathological analysis. Additionally, they offer comprehensive biostatistical support, including data evaluation, graphical and factual analysis, and the production of a detailed methodology and report at the end of the experiment.

Additional Support:

Available upon individual requests, CCP can expand their basic services to include designing and developing transgenic models for studying particular infectious diseases. This involves model verification, securing a source of the pathogen, and establishing the infectious model. They also offer new approaches to studying animal physiology and provide access to state-of-the-art equipment and experts to design and conduct complex studies. At the Czech Centre for Phenogenomics, they follow several GLP-certified procedures essential for preclinical research and certified therapeutic testing. Beyond these core services, they can customise experimental designs to meet your research needs, ensuring precise and reliable results. CCP‘s advanced imaging technologies allow for detailed physiological and pathological assessments and offer comprehensive data management solutions for robust data collection, storage, and analysis. They also collaborate with leading experts and institutions to broaden the scope and impact of your studies. Additionally, CCP provides training programs and ongoing support to help you successfully implement your research projects.

How to apply for the INFRAFRONTIER BSL-3 Preclinical Services?

Please click the button below to fill out our Service Request Form or Pbagnpg hf if you have any questions.

If you have a preferred service provider, please indicate it in the form.

Get to know the provider:

The Czech Centre for Phenogenomics (CCP) is a large research infrastructure unique in combining genetic engineering capabilities, advanced phenotyping and imaging modalities, specific pathogen free (SPF) animal housing and husbandry, as well as cryopreservation and archiving, all in one central location – at BIOCEV campus. This concentration of specialised infrastructure and expertise provides a unique and valuable resource for the biomedical and biotechnology research community.

Learn more about the Czech Centre for Phenogenomics here.

The Unit of Models of Infectious Diseases features an Animal Biosafety Level 3 (ABSL-3) laboratory with a dedicated closed husbandry facility for infectious disease research using animal models. The state-of-the-art lab is equipped with advanced technologies and supports a wide range of research modalities for studying viral, bacterial, and protozoan infections. They provide comprehensive services, including project planning, licensing, and experimental design, all supported by a team of skilled researchers proficient in both invasive and non-invasive techniques, as well as microbiological procedures. This infrastructure supports both primary academic research and preclinical testing, ensuring adherence to the highest scientific standards.

Relevant Publications
  1. Gambini F, Arbon D, Nickl P et al. New mouse model for inducible hACE2 expression enables to dissect SARS-CoV-2 pathology beyond the respiratory system. Mammalian Genome. 2025; 36(2):403-416. doi: 10.1007/s00335-025-10115-1.
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).